Dr. Joerg Schlingemann

Angestellt, Director, Head of Quality CMO, Merck KGaA, Darmstadt, Germany

Darmstadt, Deutschland

Fähigkeiten und Kenntnisse

Molecular Biology
Genetics
Proteomics
Biomedical Research
Scientific Project Management
Analytical Method Development
Computer Skills (Bioinformatics)
Gene Expression Profiling (Microarrays)
Real-Time PCR
Multiplex PCR
Proximity Ligation Assay (PLA)
Mass Spectrometry
Biacore Analysis
International Experience (Sweden)

Werdegang

Berufserfahrung von Joerg Schlingemann

  • Bis heute

    Director, Head of Quality CMO

    Merck KGaA, Darmstadt, Germany

  • 3 Jahre und 2 Monate, Mai 2013 - Juni 2016

    Group Leader & Head of Quality Control R&D

    AbbVie Deutschland GmbH & Co. KG
  • 1 Jahr und 4 Monate, Jan. 2012 - Apr. 2013

    Associate Director, GMP Compliance & Physicochemical Testing IMPs

    Biotest AG

    Biopharmaceuticals, Monoclonal antibodies

  • 1 Jahr und 7 Monate, Juni 2010 - Dez. 2011

    GMP Compliance Manager

    Biotest AG

    Biopharmaceuticals, Monoclonal antibodies

  • 11 Monate, Juli 2009 - Mai 2010

    Quality Assurance Manager

    Biotest AG

    Validation of analytical methods, Change control, Deviation management

  • 10 Monate, Sep. 2008 - Juni 2009

    Scientist

    Qiagen Hamburg GmbH

    Development and optimization of multiplex PCR assays for the detection and discrimination/typing of viral and/or bacterial pathogens

  • 2 Jahre und 10 Monate, Nov. 2005 - Aug. 2008

    Research Scientist

    Olink Bioscience

    The focus of my work was the development and optimization of a novel immuno assay (Proximity Ligation Assay; PLA) in close collaboration with Applied Biosystems. PLA is an ultra-sensitive method for the detection of proteins, protein interactions and protein modifications which is based on the proximity-dependent ligation of antibody-coupled oligonucleotides. The ligation products finally serve as templates for the read-out and quantification via real-time-PCR.

Ausbildung von Joerg Schlingemann

  • Bis heute 17 Jahre und 3 Monate, seit Apr. 2007

    Business administration & economics

    Open University Hagen

  • 2 Jahre und 10 Monate, Nov. 2005 - Aug. 2008

    Molecular Medicine, Method development

    Uppsala University

    Development of advanced molecular techniques for proteomics and medicine. Research focus: Proximity Ligation for highly sensitive protein detection

  • 3 Jahre und 11 Monate, Nov. 2001 - Sep. 2005

    Molecular Biology

    German Cancer Research Center Heidelberg (DKFZ)

    The focus of my PhD thesis was to develop new target and signal amplification techniques for expression profiling on oligonucleotide microarrays, using minimal amounts of starting material.

  • 5 Jahre, Okt. 1996 - Sep. 2001

    Molecular Biology

    Ruprecht-Karls-University Heidelberg

    Master thesis: "Profile of Gene Expression induced by the Tumor Promoter TPA in Murine Epithelial Cells"

Sprachen

  • Englisch

    Fließend

  • Deutsch

    Muttersprache

  • Schwedisch

    Fließend

  • Französisch

    Grundlagen

Interessen

Analytical and Diagnostic Methods
Business Administration
Economics
Scandinavia

21 Mio. XING Mitglieder, von A bis Z